-

05:52:51 AM

AEMD Stock News

AEMD - Aethlon Medical Inc

06/01/23 3:51 PM

Nasdaq : AEMD

conferences

Aethlon Medical to Present at the 13th Annual LD Micro Invitational

Aethlon Medical, Inc., a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that Guy Cipriani, Senior Vice President and Chief Business Officer, and James Frakes, Chief Financial Officer, will present a company overview at the...

RHEA-AI

neutral

05/22/23 8:01 AM

Nasdaq : AEMD

clinical trialcovid-19

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

Aethlon Medical, Inc., a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced that it has received Ethics Review Board approval from the Maulana Azad Medical College, for a second site for its ongoing clinical trial of Aethlon's...

RHEA-AI

neutral

02/13/23 4:15 PM

Nasdaq : AEMD

earnings

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc., a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its third quarter ended December 31, 2022 and provided an update on recent developments. Aethlon Medical is continuing the research and clinical development of...

RHEA-AI

neutral

02/06/23 8:01 AM

Nasdaq : AEMD

/C O R R E C T I O N -- Aethlon Medical, Inc./

In the news release, Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023, issued 06- Feb-2023 by Aethlon Medical, Inc. over PR Newswire, we are advised by the company that in the 1st and 2nd paragraphs, both mentions of " February 6, 2023" should read " February 13, 2023" as originally issued inadvertently.

RHEA-AI

neutral

02/06/23 8:01 AM

Nasdaq : AEMD

earnings

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023

Aethlon Medical, Inc., a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its third quarter ended December 31, 2022, at 4:15 p.m. EST on Monday, February 6, 2023. Interested parties without internet access or unable to pre-register may dial in by...

RHEA-AI

neutral

01/31/23 8:01 AM

Nasdaq : AEMD

conferences

Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, announced today that it will be presenting virtually at the

RHEA-AI

neutral

01/30/23 8:01 AM

Nasdaq : AEMD

Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

Aethlon Medical, Inc., a company developing medical technology to treat cancer and life-threatening infectious diseases, today announced that it has entered into an agreement with NAMSA, a world leading MedTech Contract Research Organization offering global end-to-end development services to oversee the company's clinical trials investigating the...

RHEA-AI

neutral

11/14/22 4:15 PM

Nasdaq : AEMD

earnings

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its second quarter ended September 30, 2022 and

RHEA-AI

neutral

11/02/22 2:43 PM

Nasdaq : AEMD

earnings

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second quarter ended September 30, 2022, at 4:15 p.m. EST on

RHEA-AI

neutral

09/06/22 8:01 AM

Nasdaq : AEMD

conferences

Aethlon Medical to Present at Two Investor Conferences in September

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that it will be presenting at two investor conferences in September.

RHEA-AI

neutral

1 2 3 4 5 6 Next